Nitric oxide (NO) in general plays a beneficial physiological role as a vasorelaxant and the
role of NO is decided by its concentration present in physiological environments. NO either …

BACKGROUND Thyroid cancer is a rare cancer, accounting for only 1% of all malignancies
in England and Wales. Differentiated thyroid cancer (DTC) accounts for≈ 94% of all thyroid …

Vascular endothelial growth factor (VEGF) is a hypoxia-induced angiogenic protein that
exhibits a broad range of neurotrophic and neuroprotective effects in the central nervous …

Background Vascular endothelial growth factor (VEGF) contributes to type 2 diabetes
(T2DM) pathogenesis, and genetic variations in VEGFA gene were suggested to influence …

Cancer progression relies on establishment of the blood supply necessary for tumor growth
and ultimately metastasis. Prostate cancer mortality is primarily attributed to development of …

Vascular endothelial growth factor (VEGF) is a multifunctional cytokine with distinct functions
in angiogenesis, lymphangiogenesis, vascular permeability, and hematopoiesis. VEGF is a …

Tissue-engineered vascular grafts are widely tested as a promising substitute for both
arterial bypass and replacement surgery. We previously demonstrated that incorporation of …

The blend of poly (3-hydroxybutyrate-co-3-hydroxyvalerate)(PHBV) and poly (ε-
caprolactone)(PCL) has recently been considered promising for vascular tissue …

Background: Cardio-oncology aims to mitigate adverse cardiovascular manifestations in
cancer survivors, but treatment-induced hypertension or aggravated hypertension has …

Background and Purpose Fostamatinib is an inhibitor of spleen tyrosine kinase (TK). In
patients, fostamatinib treatment was associated with increased BP. Some TK inhibitors …